Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art overview on biological treatment for CRSwNP
Peter W. Hellings, E.W.M. Verhoeven, Wytske J. Fokkens
Rhinology Journal (2021)
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Real‐life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps
Rik Johannes Leonardus van der Lans, Wytske J. Fokkens, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 670-674
Open Access | Times Cited: 67
Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial
Evelijn Lourijsen, Sietze Reitsma, Marleen Vleming, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 4, pp. 337-346
Closed Access | Times Cited: 64
Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective
Rik J.L. van der Lans, Claire Hopkins, Brent A. Senior, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1454-1461
Open Access | Times Cited: 39
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44
Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps
Boris Haxel, Thomas Hummel, Kai Fruth, et al.
Rhinology Journal (2022)
Closed Access | Times Cited: 34
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID‐exacerbated respiratory disease
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
Biological Therapy of Severe Asthma and Nasal Polyps
Agamemnon Bakakos, Florence Schleich, Petros Bakakos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 976-976
Open Access | Times Cited: 24
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noah Cohen, Geoffrey Chupp, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 160-168
Open Access | Times Cited: 23
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo‐controlled OSTRO trial
Claire Emson, Joseph K. Han, Claire Hopkins, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 8, pp. 1952-1963
Open Access | Times Cited: 4
Outcome measures for chronic rhinosinusitis with nasal polyps
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Andrea Ciofalo, Antonella Loperfido, Silvia Baroncelli, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access | Times Cited: 4
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease
Evelijn Lourijsen, Klementina Avdeeva, Kit Liang Gan, et al.
Cochrane library (2025) Vol. 2025, Iss. 1
Closed Access
How does asthma coexistence affect the strategic selection of biologic therapies in CRSwNP management?
İmran Özdemir, Nuray Bayar Muluk, Mustafa Yazır, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Unified Airway Disease
Wytske J. Fokkens, Sietze Reitsma
Otolaryngologic Clinics of North America (2022) Vol. 56, Iss. 1, pp. 1-10
Closed Access | Times Cited: 18
Studies on Clinical Features, Mechanisms, and Management of Olfactory Dysfunction Secondary to Chronic Rhinosinusitis
Yi‐Tsen Lin, Te‐Huei Yeh
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 17
Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
Vibeke Backer, Lars‐Olaf Cardell, Lauri Lehtimäki, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 9
Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment
Matteo Gelardi, Rossana Giancaspro, Vitaliano Nicola Quaranta, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104275-104275
Open Access | Times Cited: 3
Patterns of recurrence in patients with CRSwNP who underwent complete FESS
Lirit Levi, Shany Havazelet, Yonatan Reuven, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 11, pp. 5847-5856
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top